<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/css" href="https://imcjms.com/assets/rss.css" ?><rss version="2.0">
<channel>
    <title>IMC Journal of Medical Science</title>
    <link>https://imcjms.com</link>
    <description>Ibrahim Medical College Journal of Medical Science</description>

                        <item>
                <title><![CDATA[Simple screening tests for the detection of metallo-β-lactamase (MBL) production in clinical isolates of Pseudomonas and Acinetobacter]]></title>

                                    <author><![CDATA[Shaheda Anwar]]></author>
                                    <author><![CDATA[Md. Ruhul Amin Miah]]></author>
                                    <author><![CDATA[Ahmed Abu Saleh]]></author>
                                    <author><![CDATA[Humayun Sattar]]></author>
                                    <author><![CDATA[Sharmeen Ahmed]]></author>
                
                <link data-url="https://imcjms.com/registration/journal_full_text/185">
    https://imcjms.com/registration/journal_full_text/185
</link>
                <pubDate>Tue, 11 Apr 2017 16:40:40 +0000</pubDate>
                <category><![CDATA[Original Article]]></category>
                <comments><![CDATA[Ibrahim Med. Coll. J. 2010; 4(1): 26-30]]></comments>
                <description>There
are no standard methods for the detection of metallo-b-lactamase (MBL) production in gram negative organism in routine
microbiology practice. The present study was undertaken to evaluate the
screening tests like double disk synergy test (DDST) and disk potentiation test
(DPT) using ceftazidime (CAZ) and imipenem (IPM) disks with chelating agents
like EDTA, 2-mercaptopropionic acid (2-MPA). A total of 132 Pseudomonas and
76 Acinetobacter isolates were obtained from Bangabandhu Sheikh Mujib
Medical University (BSMMU) and Bangladesh Institute of Research and
Rehabilitation for Diabetes, Endocrine and Metabolic Disorders (BIRDEM)
hospitals of Dhaka city. A total of 53 and 29 IPM resistant Pseudomonas and
Acinetobacter isolates were selected. EDTA-IPM microdilution minimum
inhibitory concentration (EDTA-IPM MIC) method detected MBL in 44 (83%) IPM
resistant Pseudomonas and 19 (65.5%) Acinetobacter isolates. DDST
with CAZ-0.1M EDTA and CAZ-2-MPA detected MBL in 73.6% and 67.9% of IPM
resistant Pseudomonas and 55.2% and 48.3% of Acinetobacter
isolates respectively. The detection rate was 67.9% and 66.1% in Pseudomonas
and 51.7% and 44.8% in Acinetobacter isolates by EDTA-IPM and
IPM-2-MPA methods respectively. In comparison to DDST, DPT with CAZ-0.1M EDTA
showed higher sensitivity (89.7% ) and specificity (100%) for detection of MBL
in Pseudomonas and Acinetobacter. The results showed that simple
screening tests like DPT with 0.1M EDTA was able to detect MBL producing Pseudomonas
and Acinetobacter from clinical samples with high sensitivity and
specificity.
Ibrahim
Med. Coll. J. 2010; 4(1): 26-30
Address for Correspondence: Dr. Shaheda Anwar, Department of Microbiology,
Ibrahim Medical College, 122 Kazi Nazrul Islam Avenue, Shahbag, Dhaka
&amp;nbsp;
Carbepenem,
namely imipenem is the drug of choice for the treatment of infections caused by
multidrug resistant gram-negative bacilli specially Pseudomonas and Acinetobacter.
Recently, metallo-b-lactamase
(MBL), a carbepenemase, has been reported to be involved in mediating
resistance against imipenem.1&amp;nbsp;It is a class B beta-lactamase enzyme capable
of hydrolyzing all b-lactams except
monobactam and their catalytic activities are generally not inhibited by
inhibitors like clavulanic acid, salbactam and tazobactam. MBLs are sensitive
to metal chelators like EDTA and thiol based compounds and these inhibitors are
exploited to detect MBL activities of the organisms.2&amp;nbsp;Currently, there is no
recommended method for the detection of MBL in routine laboratory practice.
Therefore,
the aim of this study is to evaluate screening tests like DDST and DPT for the
detection of MBL producing Pseudomonas and Acinetobacter isolated
from clinical samples.
Materials and Methods
All the 208 isolates (132 Pseudomonas and 76 Acinetobacter)
from sputum, urine, tracheal aspirate, blood, wound swab were obtained from the
patient admitted in ICU, ward and outpatient department of BSMMU and BIRDEM
hospitals. Samples were collected from January 2009 to December 2009.
Identification and antimicrobial susceptibility testing
All the isolates were tested for imipenem susceptibility by disk
diffusion method using the Kirby-Bauer technique8&amp;nbsp;and as per the
recommendations of the NCCLS.9&amp;nbsp;Imipenem (10µg) and ceftazidime (30µg) disks
were obtained from Oxoid Ltd (Basingstoke, Hampshire, UK). Antibiotic potency
of the disks were standardized against the reference Pseudomonas ATCC
25853 strain.
Detection of MBL-production
The EDTA-IPM microdilution MIC test was a modification of EPI
microdilution MIC test as described by Migliavacca et al.10&amp;nbsp;MIC of IPM were determined
with a standard microdilution assay in 96 well microtiter plates using Mueller
Hinton broth (MHB) and a bacterial inoculum of 5x 104&amp;nbsp;CFU per well, in a final
volume of 100µl. IPM concentrations in the range of 512 to 0.5 µg/ml were
tested in the study. The MICs of IPM were determined with IPM alone and IPM
plus 0.4mM EDTA. The best results of MIC of IPM were observed with a
concentration of EDTA of 0.4mM. One well containing the bacterial suspension
alone and another well containing 0.4mM EDTA alone were used as control.
Results were recorded by visual inspection of microtiter plates after 18 hour
of incubation at 37°C. A minimum fourfold reduction in the MIC of IPM in
presence of EDTA in comparison to IPM alone was designated as the cutoff value
for detection of MBL producers.10&amp;nbsp;The test has been used as gold standard for
detection of MBLs production in this study.
2. Double disk synergy test (DDST)
&amp;nbsp;
DPT was
performed according to the method described by Galani et al.12&amp;nbsp;Three CAZ (30µg) disks and
three 10µg IPM disks were placed on the plates. The distance between every
CAZ/IPM disk was about 3-4cm from center to center. 10µl of 0.1M EDTA was added
to one CAZ/IPM disk and 10µl of 1:12 2-MPA was added to another CAZ/IPM disk.
The plate was incubated at 37°C overnight. Enlargement of the diameter of
growth inhibitory zone around CAZ/IPM+EDTA/2-MPA disk by ³7mm compared to CAZ/IPM alone was considered as positive for MBL.
Result
The
details of the results of DDST and DPT are given in Table 1 and 2. In DDST,
higher doubtful results were obtained by EDTA-IPM (5.6%) or IPM-2-MPA (7.5%)
compared to CAZ plus EDTA/2MPA disks. Similarly, higher doubtful results were
also obtained with EDTA-IPM (10.3%) or IPM-2-MPA (13.8%) for Acinetobacter
compared to CAZ-EDTA and CAZ-2-MPA by DDST. But no doubtful results have been
observed for either Pseudomonas or Acinetobacter in detecting MBL
by DPT.
Table-1: Comparison of detection of MBL positive Pseudomonas with DDST
and DPT using CAZ/IPM with EDTA and 2-MPA
&amp;nbsp;
&amp;nbsp;
Discussion
In this
study, initially different concentrations of EDTA (0.1M and 0.5M) and 2-MPA
(1:8,1:12) were used in DDST and DPT. The purpose of using different
concentrations was to identify the most optimum concentration of these agents
to detect MBL producing organism. For detection of MBL, 25 Pseudomonas and
19 Acinetobacter were tested with 0.1M and 0.5M EDTA by DDST. All gave
positive results with 0.1M EDTA without any equivocal results but with 0.5M
EDTA only 76% Pseudomonas and 73.7% Acinetobacter isolates were
positive for MBL while 24% and 26.3% showed equivocal results respectively.
Distances
of 1, 1.5, 2, 2.5,3,4 cm (from center to center) between EDTA/2-MPA and CAZ/IPM
were tested for DDST for detection of MBL production. It was found that 1-1.5
cm distance between EDTA/2-MPA and CAZ/IPM disks showed a clear and distinct
synergistic zone towards EDTA/2-MPA in DDST. 
By
comparing the sensitivity and specificity of DDST and DPT to detect MBL
producing Pseudomonas and Acinetobacter isolates, DPT with 0.1M
EDTA provided higher sensitivity and specificity results. DDST with 2-MPA
showed the lowest specificity for detection of MBL. Franklin et al
showed that DPT had 100% sensitivity and 98% specificity whereas DDST had a
sensitivity of 79% and specificity of 98%.13&amp;nbsp;DPT is preferred because of
its objective interpretation compared to DDST. Interpretation of DDST depends
on the technician’s expertise in discriminating true synergism from
intersection of the inhibitory zones.14&amp;nbsp;Also, it may be noted that the synergistic
zone of inhibition sometimes may be masked if the resistance to CAZ is
conferred by AmpC b-lactamase or
ESBL.
&amp;nbsp;
1.&amp;nbsp;&amp;nbsp; Nordmann P, and Poirel L.
Emerging carbapenemases in Gram negative aerobs. Clin Microbiol Infect
2002; 8: 321-331.
3.&amp;nbsp;&amp;nbsp; Walsh TR, Bolmstorm A,
Gales A. Evaluation of a new E-test for detecting Metallo-b-lactamases in routine clinical testing. J Clin Microbiol
2002; 40: 2755-9.
5.&amp;nbsp;&amp;nbsp; Walsh, T.R., Neville WA,
Haran MH, Tolson D, Payne J, &amp;amp; Bateson JH. Nucleotide and amino acid
sequences of the metallo-b-lactamases, ImiS, from Aeromonas
veronii bv sorbia. Antimicrob Agents Chemother 1998; 42:
436-439 .
7.&amp;nbsp;&amp;nbsp; Forbes BA, Sham DF,
Weissfeld AS. Bailey and Scott’s diagnostic Microbiology, 10th Edition. Mosby,
New York 1998; 167-87.
9.&amp;nbsp;&amp;nbsp; National Committee for
Clinical Laboratory Standards. Performance standards for Antimicrobial
Susceptibility Testing: Eleventh informational supplement. NCCLS document
M100-S11 NCCLS. Wayne, Pennsylvania 2001; USA.
11.Kim SY, Hong SG, Moland
ES, &amp;amp; Thomson SK. Convenient Test Using a Combination of Chelating Agents
for Detection of Metallo-b-lactamases in Clinical
Laboratory. Journal of Clinical Microbiology 2007; 45(9):
2798-2801.
13.Franklin C, Liolios L,
&amp;amp; Peleg A Phenotypic Detection of Carbapenem- Susceptible Metallo-b-lactamase Producing Gram-Negative Bacilli in the Clinical
Laboratory. Journal of Clinical Microbiology 2006; 44(9):
3139-3144.
</description>

            </item>
            
    <copyright>2026 Ibrahim Medical College. All rights reserved.</copyright>
</channel>
</rss>
